Literature DB >> 9327702

Comparison between iodine 123 metaiodobenzylguanidine scintigraphy and heart rate variability for the assessment of cardiac sympathetic activity in mild to moderate heart failure.

G A Somsen1, B M Szabó, D J van Veldhuisen, P A de Milliano, C A de Groot, K I Lie.   

Abstract

This study demonstrates that in patients with mild to moderate heart failure, cardiac metaiodobenzylguanidine (MIBG) washout positively correlates with normalized low-frequency power in the heart rate variability spectrum. Alterations of the cardiac sympathetic nervous system could be detected with MIBG scintigraphy in patients with normal plasma norepinephrine levels. Therefore cardiac MIBG washout may be a valuable noninvasive technique to assess early alterations in cardiac sympathetic activity that may have potential clinical implications in patients with mild to moderate heart failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327702     DOI: 10.1016/s0002-8703(97)70081-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Autonomic control of heart rate variability in vasovagal syncope: a study of the nighttime period in 24-hour recordings.

Authors:  A Lagi; C Tamburini; L Fattorini; S Cencetti
Journal:  Clin Auton Res       Date:  1999-08       Impact factor: 4.435

2.  Effect of pimobendan in patients with chronic heart failure.

Authors:  N Takeda; Y Hayashi; T Arino; A Takeda; K Noma
Journal:  Exp Clin Cardiol       Date:  2001

Review 3.  Complementary Role of Combined Indirect and Direct Cardiac Sympathetic (Hyper)Activity Assessment in Patients with Heart Failure by Spectral Analysis of Heart Rate Variability and Nuclear Imaging: Possible Application in the Evaluation of Exercise Training Effects.

Authors:  Ferdinando Iellamo; Marco Alfonso Perrone; Andrea Cimini; Giuseppe Caminiti; Agostino Chiaravalloti; Attilio Parisi; Orazio Schillaci
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-05

Review 4.  Cardiac metaiodobenzylguanidine imaging and heart failure.

Authors:  Tomoaki Nakata; Akiyoshi Hashimoto; Hirohito Sugawara
Journal:  Curr Heart Fail Rep       Date:  2013-12

5.  Validation of 2-year 123I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure.

Authors:  Kenichi Nakajima; Tomoaki Nakata; Takahiro Doi; Toshiaki Kadokami; Shinro Matsuo; Tetsuo Konno; Takahisa Yamada; Arnold F Jacobson
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-07-01       Impact factor: 6.875

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.